The AI model can identify individuals with the highest risk of pancreatic cancer up to three years prior to their formal diagnosis. A new study, led by researchers from Harvard Medical School, the University of Copenhagen, VA Boston Healthcare System, Dana-Farber Cancer Institute, and the Harvard T
An AI tool identified people at the highest risk for pancreatic cancer up to three years before actual diagnosis.
The findings point to the promise of AI for mass screening to help expedite the diagnosis of an aggressive disease often identified with serious delays.
Pancreatic cancer is one of the deadliest cancers in the world and its toll is projected to increase.
The largest clinical trial in history related to liver cancer screening is launching in 2023, funded by the Department of Veterans Affairs. The project is
American Heart Association Scientific Sessions 2022, Abstract 19443 - In a study comparing the effectiveness of two high blood pressure medications (both diuretics) among elderly veterans, there was no difference in cardiovascular outcomes or non-cancer deaths.